RFK Jr. Faces Senate Scrutiny Over Measles and Flu Deaths Amid National Preparedness Concerns

Health and Human Services Secretary Robert F. Kennedy Jr. Faced intense questioning before a U.S. Senate committee on Wednesday, April 22, 2026, regarding measles outbreaks and flu-related deaths, as public health officials expressed concern over declining vaccination rates and the federal response to preventable diseases.

The hearing, held before the Senate Health, Education, Labor, and Pensions Committee, centered on recent measles cases reported in multiple states and the ongoing impact of seasonal influenza, which has contributed to thousands of hospitalizations and deaths this year. Kennedy defended his administration’s approach to vaccine policy, emphasizing state-level flexibility in public health decisions while acknowledging the seriousness of measles as a highly contagious viral illness.

According to verified reports from the hearing, Kennedy was pressed by senators on the administration’s handling of the Centers for Disease Control and Prevention, particularly following recent leadership changes at the agency. He maintained that reforms at the CDC were necessary to improve responsiveness and transparency, rejecting claims that the changes undermined the agency’s scientific integrity during outbreaks.

Senators cited data showing measles cases in the United States had risen compared to previous years, with outbreaks linked to communities with low measles-mumps-rubella (MMR) vaccination coverage. Kennedy did not dispute the occurrence of these cases but argued that the U.S. Was managing outbreaks more effectively than many other nations, citing improved surveillance and rapid containment efforts in affected areas.

On influenza, Kennedy acknowledged the significant burden of flu season, noting that tens of thousands of Americans are hospitalized annually due to flu complications. He highlighted ongoing efforts to improve vaccine access and public awareness, though he refrained from endorsing any specific federal mandate for flu vaccination, instead advocating for education and outreach through state and local health departments.

The hearing also touched on long COVID, with Senator Todd Young of Indiana questioning the administration’s research initiatives into the condition, which affects millions of Americans experiencing persistent symptoms after SARS-CoV-2 infection. Kennedy stated that the National Institutes of Health continues to fund studies into long COVID’s mechanisms and potential treatments, though he did not announce new funding or policy shifts during the proceeding.

Throughout the session, Kennedy rejected accusations that his policies were contributing to vaccine hesitancy, asserting that his focus remains on informed consent and scientific rigor in vaccine development and monitoring. He denied allegations of pressuring CDC officials to alter vaccine recommendations, calling such claims unfounded and politically motivated.

Public health experts outside the hearing have warned that gaps in vaccination coverage, particularly for measles, pose a growing risk of sustained transmission, given that measles requires approximately 95% population immunity to prevent outbreaks. The World Health Organization and CDC have both reported increases in measles cases globally in recent years, attributing the trend to disruptions in routine immunization during the pandemic and ongoing vaccine access challenges in certain regions.

As of the date of the hearing, no federal emergency declarations had been issued regarding measles or flu, though state health departments in several jurisdictions had issued alerts urging vaccination and early treatment for symptomatic individuals. Kennedy reiterated that the administration supports robust surveillance systems and rapid response capabilities at the state level, which he said are critical to containing infectious disease threats before they spread widely.